Active Surveillance for Prostate Cancer in Older Men.

Prostate cancer is a common disease, affecting 1 in 8 men. The risk of mortality from untreated prostate cancer is limited in the first 5 to 10 years after treatment and as a result, the benefit of treatment is in men with greater than 10 years of life expectancy. When life expectancy is more limited, options for non-curative intervention include active surveillance, de-intensified surveillance, and watchful waiting. In this review, these strategies will be discussed.